These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance. Ryan MR; Stastny JF; Remmers R; Pedigo MA; Cahill LA; Frable WJ Am J Clin Pathol; 1996 Jun; 105(6):711-8. PubMed ID: 8659445 [TBL] [Abstract][Full Text] [Related]
3. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy. O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746 [TBL] [Abstract][Full Text] [Related]
4. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study. Dane C; Batmaz G; Dane B; Cetin A Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953 [TBL] [Abstract][Full Text] [Related]
5. PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma. Sherman ME; Mango LJ; Kelly D; Paull G; Ludin V; Copeland C; Solomon D; Schiffman MH Mod Pathol; 1994 Jun; 7(5):578-81. PubMed ID: 7937724 [TBL] [Abstract][Full Text] [Related]
6. Clinical implication of atypical squamous cells of undetermined significance with or without favoring high-grade squamous intraepithelial lesion on cervical smears. ChangChien CC; Lin H; Eng HL; Chang WK Changgeng Yi Xue Za Zhi; 1999 Dec; 22(4):579-85. PubMed ID: 10695204 [TBL] [Abstract][Full Text] [Related]
7. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Levi AW; Kelly DP; Rosenthal DL; Ronnett BM Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979 [TBL] [Abstract][Full Text] [Related]
9. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up. Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460 [TBL] [Abstract][Full Text] [Related]
10. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Lonky NM; Felix JC; Naidu YM; Wolde-Tsadik G Obstet Gynecol; 2003 Mar; 101(3):481-9. PubMed ID: 12636951 [TBL] [Abstract][Full Text] [Related]
11. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H]. Wu Y; Zhao J; Hu J; Wu XW; Zhu LR Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267 [No Abstract] [Full Text] [Related]
12. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears. van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the PAPNET system in a general pathology service. Farnsworth A; Chambers FM; Goldschmidt CS Med J Aust; 1996 Oct; 165(8):429-31. PubMed ID: 8913244 [TBL] [Abstract][Full Text] [Related]
14. Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis. Lonky NM; Navarre GL; Saunders S; Sadeghi M; Wolde-Tsadik G Obstet Gynecol; 1995 May; 85(5 Pt 1):716-20. PubMed ID: 7724102 [TBL] [Abstract][Full Text] [Related]
15. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience. Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072 [TBL] [Abstract][Full Text] [Related]
16. Cervicography combined with repeat Papanicolaou test as triage for low-grade cytologic abnormalities. Eskridge C; Begneaud WP; Landwehr C Obstet Gynecol; 1998 Sep; 92(3):351-5. PubMed ID: 9721768 [TBL] [Abstract][Full Text] [Related]
17. Is it possible to define a better ASCUS class in cervicovaginal screening? A review of 187 cases. Guerrini L; Sama D; Visani M; Cotignoli T; Sintoni C; Maioli P; Lanzanova G; Schincaglia P Acta Cytol; 2001; 45(4):532-6. PubMed ID: 11480714 [TBL] [Abstract][Full Text] [Related]
18. Significance of atypical squamous cells of undetermined significance on ThinPrep papanicolaou smears. Eltabbakh GH; Lipman JN; Mount SL; Morgan A Gynecol Oncol; 2000 Oct; 79(1):44-9. PubMed ID: 11006029 [TBL] [Abstract][Full Text] [Related]
19. Do qualifiers of ASCUS distinguish between low- and high-risk patients? Malik SN; Wilkinson EJ; Drew PA; Bennett BB; Hardt NS Acta Cytol; 1999; 43(3):376-80. PubMed ID: 10349365 [TBL] [Abstract][Full Text] [Related]
20. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]